Medtronic's patent dispute with Boston Scientific heads to Supreme Court


The nation's highest court has agreed to hear a lengthy patent infringement fight between Medtronic Inc. and Boston Scientific over medical devices, the Star Tribune reports.

Last September, a federal appeals court overturned a previous opinion and ruled that Medtronic must prove it didn't infringe on the patents held by Mirowski Family Ventures and controlled by rival Boston Scientific.

The Fridley-based medical device maker wants the U.S. Supreme Court to reverse that decision. The nine justices will take up the case during the court's next session that starts in October.

Reuters notes the case stems from cardiac rhythm management technology, which gives the heart an electrical shock when it fails to pump blood properly.

If Medtronic loses, the company could be required to pay millions of dollars in royalties, as well as potential damages and legal fees.

Next Up